Physician perspectives on the burden and management of asthma in six countries: The Global Asthma Physician Survey (GAPS)

Kenneth R. ChapmanDavid Hinds, Peter Piazza,Chantal Raherison,Michael Gibbs,Timm Greulich,Kenneth Gaalswyk,Jiangtao Lin,Mitsuru Adachi and Kourtney J. Davis

Abstract

Background

Despite recognition of asthma as a growing global issue and development of global guidelines, asthma treatment practices vary between countries. Several studies have reported patients’ perspectives on asthma control. This study presents physicians’ perspectives and strategies for asthma management.

Methods

Physicians seeing ≥4 adult patients with asthma per month in Australia, Canada, China, France, Germany, and Japan were surveyed (N=1809; ≈300 per country). A standardised questionnaire was developed for this study and administered by telephone, online or face-to-face. Statistics were weighted to account for the sampling scheme.

Results

Physicians estimated that 71% of their adult patients received maintenance medication, with adherence monitored by 76–97% of physicians. Perceived major barriers to patient adherence included: patients taking treatment as needed; acceptance of symptoms; and patients not perceiving treatment benefits. Written action plans (37%) and technology (15%) were seldom employed by physicians to aid patients’ asthma management. Physicians rarely (10%) used validated patient-reported questionnaires to monitor asthma control, instead monitoring selected symptoms, exacerbations, and/or lung function measurements. Awareness of single maintenance and reliever therapy (SMART/MART) varied among countries (56–100%); although most physicians (72%) had prescribed SMART/MART, the majority (91%) co-prescribed a short-acting bronchodilator at least some of the time.

Conclusions

These results show that physicians generally do not employ standardised tools to monitor asthma control or to manage its treatment and that despite high awareness of SMART/MART, the strategy appears to be commonly misapplied. Better education for patients and physicians is required to improve asthma management and resulting patient outcomes.

Download PDF

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @Aller_MD: “JAK Inhibitors Showing Promise for Many Skin Problems Conditions ranging from alopecia to vitiligo” https://t.co/mSR0or0JM5
6hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: Carina Venter PhD RD on Twitter: "A few months ago Cat’s in the Crad… https://t.co/hSf86Y42Qo, see more https://t.…
6hreplyretweetfavorite
Interasma RT @Aller_MD: “Mechanistic insights on topical tacrolimus for the treatment of atopic dermatitis” https://t.co/YFs34eAADf https://t.co/UZMa
6hreplyretweetfavorite
Interasma RT @Aller_MD: Upper and lower airway remodelling mechanisms in #asthma, #allergic rhinitis and chronic #rhinosinusitis: the one airway conc…
6hreplyretweetfavorite
Interasma RT @Aller_MD: Hot Topics: Recent Developments in Dermatologic Therapies https://t.co/w5mnT5B566 https://t.co/Vj5jJmgoO6
11hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma